Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.84B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 3 |
Nike
NKE
|
+$1.17B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$922M |
| 5 |
Hewlett Packard
HPE
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.14B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.13B |
| 3 |
Broadcom
AVGO
|
+$625M |
| 4 |
UnitedHealth
UNH
|
+$584M |
| 5 |
Mastercard
MA
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Financials | 9.75% |
| 3 | Consumer Discretionary | 7.43% |
| 4 | Healthcare | 7.41% |
| 5 | Industrials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
LifeMD
LFMD
$172M
| $900K | ﹤0.01% |
165,404
-244,145
| -60% | -$1.39M |
|
4727
Invesco S&P 500 Equal Weight Real Estate ETF
RSPR
$102M
| $899K | ﹤0.01% |
25,179
+15,467
| +159% | +$550K |
|
4728
CALL
Gilead Sciences
GILD
$165B
| $896K | ﹤0.01% |
8,000
-34,600
| -81% | -$3.57M |
|
4729
CALL
XP
XP
$8.39B
| $895K | ﹤0.01% |
65,100
+55,100
| +551% | +$759K |
|
4730
CALL
United Therapeutics
UTHR
$23.1B
| $894K | ﹤0.01% |
+2,900
| New | +$994K |
|
|
YMAB
4731
DELISTED
Y-mAbs Therapeutics
YMAB
| $894K | ﹤0.01% |
201,776
-17,399
| -8% | -$101K |
|
|
FSHP
4732
Flag Ship Acquisition Corp
FSHP
| $893K | ﹤0.01% |
86,443
| – | – |
|
4733
SkinHealth Systems
SKIN
$85.7M
| $892K | ﹤0.01% |
665,706
+31,880
| +5% | +$48.6K |
|
4734
Calvert US Mid-Cap Core Responsible Index ETF
CVMC
$109M
| $892K | ﹤0.01% |
15,725
-9,623
| -38% | -$575K |
|
4735
STRATTEC Security
STRT
$361M
| $890K | ﹤0.01% |
22,548
+6,624
| +42% | +$284K |
|
4736
Citizens & Northern Corp
CZNC
$455M
| $889K | ﹤0.01% |
44,202
-932
| -2% | -$19K |
|
4737
State Street SPDR FactSet Innovative Technology ETF
XITK
$78.1M
| $889K | ﹤0.01% |
5,557
| – | – |
|
|
ACRE
4738
Ares Commercial Real Estate
ACRE
$270M
| $888K | ﹤0.01% |
191,731
-23,323
| -11% | -$123K |
|
4739
C&F Financial
CFFI
$286M
| $887K | ﹤0.01% |
13,155
+1,339
| +11% | +$100K |
|
|
JBIO
4740
Jade Biosciences
JBIO
$1.34B
| $885K | ﹤0.01% |
10,076
+1,094
| +12% | +$96.1K |
|
4741
Vuzix
VUZI
$224M
| $885K | ﹤0.01% |
433,900
+162,229
| +60% | +$531K |
|
4742
Lifeway Foods
LWAY
$481M
| $885K | ﹤0.01% |
36,179
-9,935
| -22% | -$223K |
|
|
PAL
4743
Proficient Auto Logistics
PAL
$204M
| $884K | ﹤0.01% |
105,585
+61,272
| +138% | +$606K |
|
4744
Limoneira
LMNR
$251M
| $883K | ﹤0.01% |
49,803
-17,252
| -26% | -$375K |
|
|
CRGX
4745
DELISTED
CARGO Therapeutics
CRGX
| $882K | ﹤0.01% |
216,759
-13,793
| -6% | -$92.4K |
|
4746
Orion Group Holdings
ORN
$418M
| $881K | ﹤0.01% |
168,423
-45,336
| -21% | -$317K |
|
4747
ReNew
RNW
$2.25B
| $880K | ﹤0.01% |
149,322
-173,281
| -54% | -$1.12M |
|
|
CWBC
4748
Community West Bancshares
CWBC
$684M
| $879K | ﹤0.01% |
47,590
-2,690
| -5% | -$50.4K |
|
4749
Humacyte
HUMA
$194M
| $879K | ﹤0.01% |
515,698
-112,028
| -18% | -$421K |
|
4750
Climb Global Solutions
CLMB
$519M
| $879K | ﹤0.01% |
31,732
-42,320
| -57% | -$1.31M |
|
Similar funds
Goldman Sachs's Q1 2025 Portfolio in Review
As of Q1 2025, Goldman Sachs held 6,539 positions worth $618B, down 2.6% from $634B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs's Q1 2025 filing shows 547 new, 2,373 increased, 2,724 reduced and 514 closed positions. Its largest new stake was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M. The largest sale was TC Energy, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q1 2025 buy was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q1 2025, an estimated $1.84B increase.
- Goldman Sachs's biggest Q1 2025 reduction was TC Energy, cutting an estimated $1.14B.
- Goldman Sachs fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $242M.
- Goldman Sachs's ten largest holdings make up 20% of its $618B portfolio in Q1 2025.
- Goldman Sachs opened 547 new positions and closed 514 in Q1 2025.
- Goldman Sachs's portfolio value fell 2.6% quarter-over-quarter to $618B.
Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.